GenVec competitorsClear all

GenVec's top competitors include Phathom Pharmaceuticals, InhibRx, Dyne Therapeutics and StrideBio.
GenVec
GenVec
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
Phathom Pharmaceuticals
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders.
InhibRx
InhibRx
InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates.
Dyne Therapeutics
Dyne Therapeutics
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
StrideBio
StrideBio
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
Founding Date
Founding Date
1992
Founding Date
2018
Founding Date
2017
Founding Date
2018
Founding Date
2015
Type
Type
Subsidiary
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Gaithersburg, US HQ
Locations
HQ
Locations
La Jolla, US HQ
Locations
HQ
Locations
Durham, US HQ
Employees
Employees
N/A
Employees
12200% increase
Employees
632% increase
Employees
2216% increase
Employees
25
Twitter followers
Twitter followers
268
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
171
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
1298313
Alexa Website Rank
878625
Alexa Website Rank
161122
Alexa Website Rank
256638
Alexa Website Rank
286177

Financial

Net income
Net income
($5.8m) (FY, 2016)
Net income
($1.3m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 90m (5 months ago)
Latest funding round
$ 40m (5 months ago)
Latest funding round
$ 50m (7 months ago)
Latest funding round
$ 15.7m (over 1 year ago)
Total funding raised
Total funding raised
$ 2m
Total funding raised
$ 140m
Total funding raised
$ 43.6m
Total funding raised
$ 50m
Total funding raised
$ 15.7m
For sources of this data, please see the company profile

View company profiles

Phathom Pharmaceuticals
HQ
Employees
12

Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders.

View company
InhibRx
HQ
La Jolla, US
Employees
63↑ 2% increase

InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates.

View company
Dyne Therapeutics
HQ
Employees
22↑ 16% increase

Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.

View company
StrideBio
HQ
Durham, US
Employees
25

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.

View company